CLINICAL_TRIALS
trial_result
· 2019-11-29
Clinical Trial Update: Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Summary
Phase 2 dose-ranging study of danirixin in COPD completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED | Results posted: 2019-11-29